IP Portfolio strategies built around your business

A patent portfolio is only as strong as the thinking behind it. Too many companies accumulate patents without a clear picture of how each one supports their commercial goals, blocks competitors, or creates licensing opportunities. That is where we come in.

At IP-DEAL, we help pharmaceutical, biotech, and technology companies take a structured approach to their intellectual property assets. We audit what you have, identify what is missing, and build a plan that turns your portfolio into a genuine business tool rather than a collection of filings.

Our work includes portfolio gap analysis, competitive benchmarking, patent landscaping, and the development of filing strategies that match your R&D pipeline and market expansion plans. We also advise on portfolio optimization, helping you decide which patents to maintain, which to let go, and where new filings would add the most value.

IP Portfolio Strategies meeting room

"The best IP portfolios are not the biggest. They are the ones where every asset has a clear reason to exist."

FAQs

  • An IP portfolio strategy is a plan for building, managing, and using your patent and trademark assets in a way that supports your business objectives. It covers filing decisions, geographic coverage, maintenance and pruning, competitive positioning, and monetization opportunities like licensing or cross-licensing.

  • Without active management, portfolios become bloated and expensive. You end up paying maintenance fees on patents that no longer align with your product line while leaving real gaps in protection. A managed portfolio costs less, covers more, and gives you stronger leverage in negotiations, disputes, and transactions.

  • A patent landscape analysis maps out who holds patents in a given technology space, where clusters of activity exist, and where white space remains. It helps you see your competitive position clearly and find areas where new filings could give you an advantage. We run these analyses using both technical and commercial lenses.

  • Yes. We assess the commercial relevance of individual patents and portfolio segments to support licensing negotiations, M&A transactions, investor discussions, and internal resource allocation. Our valuations look at technical scope, market coverage, enforceability, and remaining patent life.

  • We evaluate each patent family against your current business activities, product pipeline, competitive landscape, and licensing potential. Patents that do not protect an active product, block a competitor, or hold licensing value are candidates for abandonment. This frees up budget for filings that actually matter.

  • Absolutely. Most of our clients have internal patent counsel or an IP department. We work alongside them, adding bandwidth and an outside perspective. We handle the strategic analysis and recommendations while your team manages day-to-day prosecution and maintenance.

EXPLORE OUR SERVICES